Richard Ferrari Overview
- Company
- HeartBeam
- Primary Position
-
Chairman & Board...
- Primary Industry
-
Healthcare
- Active Board Seats
-
10
- Med. Deal Size
-
000.0
- Med. Valuation
-
000.0
Richard Ferrari General Information
Biography
Mr. Richard Ferrari is a Co-Founder and serves as Executive Chairman & Managing Director at De Novo Ventures. He served as a Board Member at Endoshape. He serves as a Board Member at Hawthorne Effect, Evren Technologies, HeartBeam, PuraCath Medical, and Benvenue Medical, and Chairman of the Board of Directors at MedLumics. He serves as an Advisor at SellHound. He also serves as Chairman, Chief Executive Officer, and President at PQ Bypass. He is also an Angel Investor. He also serves as a Board Member at Advanced Bifurcation Systems. He served as a Board Member at Biomodex. Additionally, he has been a successful CEO of two publicly traded medical technology companies. Cardiovascular Imaging Systems, the first and leading developer of ultrasound imaging catheters was eventually acquired for $125 million by Boston Scientific. His most recent success, CardioThoracic Systems (CTS), the market leader in disposable instruments and systems for performing minimally invasive beating heart bypass surgery, was acquired by Guidant for $350 million in November 1999. He was a co-founder of CTS and the force that led the company to an initial public offering in only 7 months, the fastest of any medical technology company in history. He co-founded the Medical Technology Group which spun out Integrated Vascular Systems, acquired by Abbot Vascular and Ensure, acquired by J&J. He also serves as a faculty member of the Stanford Biodesign Emerging Entrepreneurs Forum, as well as a board member for the Stanford | Coulter Foundation for Translational Medicine. Previously he held the positions of Executive Vice President and General Manager of ADAC Laboratories. He also served as Business Development Advisor at Saratoga Ventures. He is the recipient of the Mallinckrodt Award for Excellence in Medicine and has been a finalist for the Entrepreneur of the Year Award. He is a serial medical device entrepreneur. He is a serial entrepreneur and has strong skills in entrepreneur coaching, inspiring, and mentoring first-time CEOs and investors on how to achieve the most from their organization. He holds a BS degree from Ashland University and an MBA from the University of South Florida.
Contact Information
Address
- 2118 Walsh Avenue
- Suite 210
- Santa Clara, CA 95050
- United States
Richard Ferrari Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
De Novo Ventures | Investor | Co-Founder, Executive Chairman & Managing Director | Saratoga, CA | Venture Capital | 0000-00-00 |
Richard Ferrari Board Seats (10)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Advanced Bifurcation Systems | Surgical Devices | Privately Held (backing) | Venture Capital-Backed | Livermore, CA | |
De Novo Ventures | Saratoga, CA | 0000-00-0 | |||
Empirical Spine | Surgical Devices | Privately Held (backing) | Venture Capital-Backed | San Carlos, CA | 0000-00-0 |
Evren Technologies | Therapeutic Devices | Privately Held (backing) | Venture Capital-Backed | Newberry, FL | 0000-00-0 |
Hawthorne Effect | Other Healthcare Technology Systems | Privately Held (backing) | Venture Capital-Backed | Lafayette, CA |
Richard Ferrari Lead Partner on Deals (39)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
PuraCath Medical | 23-Jun-2020 | Later Stage VC (Series A) | 00000 | Completed | Other Devices and Supplies | San Francisco, CA |
Pulmonx | 05-May-2020 | 00000 00000 00 | 0000 | Completed | Other Devices and Supplies | Redwood City, CA |
Benvenue Medical | 06-Jan-2016 | 00000 00000 00 | 0000 | Completed | Therapeutic Devices | Santa Clara, CA |
Benvenue Medical | 18-Jun-2014 | 00000 00000 00 | 0000 | Completed | Therapeutic Devices | Santa Clara, CA |
Spinal Kinetics | 02-Jun-2014 | 00000 00000 00 | 0000 | Completed | Surgical Devices | Sunnyvale, CA |
Pacira CryoTech | 12-Sep-2013 | 00000 00000 00 | 0000 | Completed | Therapeutic Devices | Fremont, CA |
Pacira CryoTech | 12-Sep-2013 | 00000 00000 00 | 0000 | Completed | Therapeutic Devices | Fremont, CA |
Benvenue Medical | 22-May-2013 | 00000 00000 00 | 0000 | Completed | Therapeutic Devices | Santa Clara, CA |
Pacira CryoTech | 21-Mar-2012 | Later Stage VC (Series D) | 0000 | Completed | Therapeutic Devices | Fremont, CA |
Pacira CryoTech | 21-Mar-2012 | Later Stage VC (Series D) | 0000 | Completed | Therapeutic Devices | Fremont, CA |
Richard Ferrari Network (291)
Board Members (160)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Michael Rasooly | PuraCath Medical | Self | San Francisco, CA | |
Pablo Cironi Ph.D | MedLumics | Caixa Capital Risc | Madrid, Spain | 0000-00-00 |
0000 0000 | Hawthorne Effect | Hawthorne Effect | Lafayette, CA | 0000-00-00 |
000000 00 0 | HeartBeam | Self | Santa Clara, CA | 0000-00-00 |
000000 0000 | Pulmonx | Montreux Equity Partners | Redwood City, CA |
Portfolio Executives (127)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Ben Zadik | PuraCath Medical | Chief Financial Officer | 23-Jun-2020 | San Francisco, CA |
Don Canal | PuraCath Medical | Quality and Regulatory Affairs Advisor | 23-Jun-2020 | San Francisco, CA |
0000000 0 | PuraCath Medical | Vice President, Research & Development | 23-Jun-2020 | San Francisco, CA |
000000 00 | PuraCath Medical | Chief Financial Officer | 23-Jun-2020 | San Francisco, CA |
0000000 0 | PuraCath Medical | Advisory Board Member | 23-Jun-2020 | San Francisco, CA |
Fund Team Members (4)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Frederick Dotzler | De Novo Ventures | De Novo Ventures II | Saratoga, CA |
Frederick Dotzler | De Novo Ventures | De Novo Ventures III | Saratoga, CA |
000000 00000 | De Novo Ventures | 00 0000 0000 | Saratoga, CA |
000000 00000 | De Novo Ventures | 00 0000 0000 | Saratoga, CA |
000 0000000 | De Novo Ventures | 00 0000 0000 | Saratoga, CA |
Richard Ferrari Affiliated Funds (6)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Saratoga Ventures VI | Saratoga Ventures | Venture - General | Liquidated | 2008 | 00.00 | 000000 | 000000 | |
Saratoga Ventures I | Saratoga Ventures | Venture - General | Liquidated | 1998 | 00.00 | 000000 | 000000 | |
Saratoga Ventures III | Saratoga Ventures | Venture - General | Liquidated | 2000 | 00.00 | 000000 | 000000 | |
Saratoga Ventures V | Saratoga Ventures | Venture - General | Liquidated | 2006 | 00.00 | 000000 | 000000 | |
De Novo Ventures II | De Novo Ventures | Venture Capital - Early Stage | Liquidated | 2003 | 00000 | 000000 | -00.0 | 000000 |
Richard Ferrari Advisory Roles (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
SellHound | Company | Advisor | Santa Cruz, CA | Business/Productivity Software |
Richard Ferrari FAQs
-
Who is Richard Ferrari?
Mr. Richard Ferrari is a Co-Founder and serves as Executive Chairman & Managing Director at De Novo Ventures.
-
How much does Richard Ferrari typically invest?
Richard Ferrari's median deal size is 000000.
-
What is Richard Ferrari’s main position?
Richard Ferrari’s primary position is Chairman & Board Member.
-
How many active board seats does Richard Ferrari hold?
Richard Ferrari holds 10 board seats including Advanced Bifurcation Systems, De Novo Ventures, Empirical Spine, Evren Technologies, and Hawthorne Effect.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »